Back to top

News

Breaking News – Global RHD debate confirmed at WHO Executive Board

24 January 2017

The 140th session of the World Health Organization’s Executive Board – also known as ‘EB 140’ – began today in Geneva, Switzerland.

Read More »

Investigative journalist turns attention to worldwide penicillin shortage

23 January 2017

An award winning international journalist has received a major grant to investigate the worldwide shortage of Benzathine Penicillin G (BPG).

Read More »

Rheumatic Heart Disease: from Molecules to the Global Community - Summary Day 3

17 January 2017

Discussions on rheumatic heart disease (RHD) prevention and screening, pathology, and RHD management were the focus on Sunday 15 January, the second full day of ‘Rheumatic Heart Disease: from Molec

Read More »

Fiji launches “Benza” campaign highlighting importance of treatment… even if you feel well!

16 January 2017

The Fiji RHD Control Program recently launched the "Benza" (benzathine penicillin G) campaign to highlight the importance of ongoing treatment for rheumatic fever and rheumatic heart disease.

Read More »

Rheumatic Heart Disease: from Molecules to the Global Community - Summary Day 2

16 January 2017

Saturday 14 January marked the official opening of ‘Rheumatic Heart Disease: from Molecules to the Global Community’, a meeting convened by the Aswan Heart Ce

Read More »

Rheumatic Heart Disease: from Molecules to the Global Community – Summary of Day 1

14 January 2017

From 13-16 January, RHD Action is participating in ‘Rheumatic Heart Disease: from Molecules to the Global Community’, a conference on rheumatic heart disease held in Cairo, Egypt.

Read More »

WHO and IVI Host Global Consultation on Group A Streptococcal Vaccine Development

09 January 2017

The World Health Organization (WHO) and the International Vaccine Institute (IVI) recently co-hosted the Global Stakeholder Consultation on Group A Streptococcal (GAS) Vaccine Development. The Global Stakeholder Consultation took place from December 12-13 in Seoul, Republic of Korea.

Read More »

Egyptian Travel Award for African Researchers: RHD from Molecules to the Global Community Meeting

16 December 2016

The Rheumatic Heart Disease from Molecules to the Global Community Meeting is scheduled to take place in Cairo, Egypt from the 13th to 16th of January 2017.

The Egyptian Ministry of Foreign Affairs via Egyptian Agency of Partnership and Development (EAPD) has graciously made available 20 travel grants to assist attendance of African Researchers in RHD (economy airfare and accommodation). These travel grants are available to those that submit an abstract that is accepted to the congress.

Read More »

RHD Action Attends the 2016 Global Symposium on Health Systems Research

13 December 2016

From 14-18 November, WHF Policy and Advocacy Manager Joanna Markbreiter participated in the Fourth Global Symposia on Health Systems Research in Vancouver, Canada. This year’s symposium was on the theme of ‘Resilient and responsive health systems for a changing world’ and brought together over 2,000 delegates from 101 countries. 

Read More »

RHD Action to participate in the WHO Executive Board meeting in January 2017

09 December 2016

From 23 January to 01 February 2017, the World Heart Federation – a founding member of RHD Action – will participate in the 140th session of the Executive Board (EB), hosted by the World Health Organization (WHO) at its headquarters in Geneva, Switzerland.

Read More »

Pages